GlioMODA: Robust glioma segmentation in clinical routine

Date
2026-02-12
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Oxford University Press
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract

Background: Precise glioma segmentation in magnetic resonance imaging (MRI) is essential for accurate diagnosis, optimal treatment planning, and advancing clinical research. However, most deep learning approaches require complete, standardized MRI protocols that are frequently unavailable in routine clinical practice. This study presents and evaluates GlioMODA, a robust deep learning framework designed for automated glioma segmentation that delivers consistent high performance across varied and incomplete MRI protocols.

Methods: GlioMODA was trained and validated on the BraTS 2021 dataset (1251 training, 219 testing cases), systematically assessing performance across 11 clinically relevant MRI protocol combinations. Segmentation accuracy was evaluated using Dice similarity coefficients (DSC) and panoptic quality metrics. Volumetric accuracy was benchmarked against manual ground truth, and statistical significance was established via Wilcoxon signed‑rank tests with Benjamini-Yekutieli correction.

Results: GlioMODA demonstrated state-of-the-art segmentation accuracy across tumor subregions, maintaining robust performance with incomplete or heterogeneous MRI protocols. Protocols including both T1-weighted contrast-enhanced and T2-FLAIR sequences yielded volumetric differences vs manual ground truth that were not statistically significant for enhancing tumor (median difference 55 mm³, P = .157) and whole tumor (median difference -7 mm³, P = 1.0), and exhibited median DSC differences close to zero relative to the 4‑sequence reference protocol. Omitting either sequence led to substantial and significant volumetric errors.

Conclusions: GlioMODA facilitates reliable, automated glioma segmentation using a streamlined 2‑sequence protocol (T1‑contrast + T2‑FLAIR), supporting clinical workflow optimization and broader implementation of quantitative volumetry compatible with RANO 2.0 criteria. GlioMODA is published as an open-source, easy-to-use Python package at https://github.com/BrainLesion/GlioMODA/.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Canisius J, Buchner J, Rosier M, et al. GlioMODA: Robust glioma segmentation in clinical routine. Neurooncol Adv. 2026;8(1):vdag034. Published 2026 Feb 12. doi:10.1093/noajnl/vdag034
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Neuro-Oncology Advances
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}